Bakwatanisa Bosco

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

Leukemia

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Handong Sun, Lishen Zhang, Zhonglin Wang, Danling Gu, Mengyan Zhu, Yun Cai, Lu Li, Jiaqi Tang, Bin Huang, Bakwatanisa Bosco, Ning Li, Lingxiang Wu, Wei Wu, Liangyu Li, Yuan Liang, Lin Luo, Quanzhong Liu, Yanhui Zhu, Jie Sun, Liang Shi, Tiansong Xia, Chuang Yang, Qitong Xu, Xue Han, Weiming Zhang, Jianxia Liu, Dong Meng, Hua Shao, Xiangxin Zheng, Shuqin Li, Hua Pan, Jing Ke, Wenying Jiang, Xiaolan Zhang, Xuedong Han, Jian Chu, Hongyin An, Juyan Ge, Chi Pan, Xiuxing Wang, Kening Li, Qiang-Hu Wang, Qiang Ding
Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer. Nature communications 14 (1) (2023)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia 37 (2) (2022)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia 37 (2) (2022)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia 37 (2) (2022)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia 37 (2) (2022)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia 37 (2) (2022)
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qiang-Hu Wang, Ming Hong, Sixuan Qian
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia. Leukemia (2022)
Kening Li, Bin Huang, Min Wu, Aifang Zhong, Lu Li, Yun Cai, Zhihua Wang, Lingxiang Wu, Mengyan Zhu, Jie Li, Ziyu Wang, Wei Wu, Wanlin Li, Bakwatanisa Bosco, Zhenhua Gan, Qinghua Qiao, Jian Wu, Qiang-Hu Wang, Shukui Wang, Xinyi Xia
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nature communications 11 (1) (2020)

Bakwatanisa Bosco.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bakwatanisa Bosco